Trial Outcomes & Findings for Lateral Versus Anterior Spanning External Fixator for Tibial Plateau Fractures (NCT NCT00610701)
NCT ID: NCT00610701
Last Updated: 2017-07-24
Results Overview
measurement of quadriceps muscle strength at final followup = 1 year data at interim time points recorded, but only final reported for this purpose
Recruitment status
TERMINATED
Study phase
NA
Target enrollment
35 participants
Primary outcome timeframe
(admission, 6 weeks, 3 months, 6 months) 1 year
Results posted on
2017-07-24
Participant Flow
Participant milestones
| Measure |
1 Anterior
Anterior
Anterior pin placement: Anteriorly-placed (front of the leg) femoral external fixator pins
|
2 Lateral
Lateral
Lateral pin placement: Laterally-placed (side of the leg) femoral external fixator pind
|
|---|---|---|
|
Overall Study
STARTED
|
15
|
20
|
|
Overall Study
COMPLETED
|
5
|
9
|
|
Overall Study
NOT COMPLETED
|
10
|
11
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Lateral Versus Anterior Spanning External Fixator for Tibial Plateau Fractures
Baseline characteristics by cohort
| Measure |
1-anterior Pin Placement
n=5 Participants
Anterior
Anterior pin placement: Anteriorly-placed (front of the leg) femoral external fixator pins
|
2-lateral Pin Placement
n=9 Participants
Lateral
Lateral pin placement: Laterally-placed (side of the leg) femoral external fixator pind
|
Total
n=14 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
5 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
14 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
2 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
7 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
3 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
7 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
5 participants
n=5 Participants
|
9 participants
n=7 Participants
|
14 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: (admission, 6 weeks, 3 months, 6 months) 1 yearmeasurement of quadriceps muscle strength at final followup = 1 year data at interim time points recorded, but only final reported for this purpose
Outcome measures
| Measure |
1-anterior Pin Placement
n=5 Participants
Anterior
Anterior pin placement: Anteriorly-placed (front of the leg) femoral external fixator pins
|
2-lateral Pin Placement
n=9 Participants
Lateral
Lateral pin placement: Laterally-placed (side of the leg) femoral external fixator pind
|
|---|---|---|
|
Quadriceps Strength
|
35.9 Nm
Standard Deviation 10.7
|
39.6 Nm
Standard Deviation 17.7
|
Adverse Events
1 Anterior
Serious events: 2 serious events
Other events: 0 other events
Deaths: 0 deaths
2 Lateral
Serious events: 3 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
| Measure |
1 Anterior
n=5 participants at risk
Anterior
Anterior pin placement: Anteriorly-placed (front of the leg) femoral external fixator pins
|
2 Lateral
n=9 participants at risk
Lateral
Lateral pin placement: Laterally-placed (side of the leg) femoral external fixator pind
|
|---|---|---|
|
Injury, poisoning and procedural complications
death
|
20.0%
1/5 • Number of events 1 • 1 year
14 patients completed the study
|
22.2%
2/9 • Number of events 2 • 1 year
14 patients completed the study
|
|
Infections and infestations
infection
|
0.00%
0/5 • 1 year
14 patients completed the study
|
11.1%
1/9 • Number of events 1 • 1 year
14 patients completed the study
|
|
Musculoskeletal and connective tissue disorders
arthrofibrosis
|
20.0%
1/5 • Number of events 1 • 1 year
14 patients completed the study
|
0.00%
0/9 • 1 year
14 patients completed the study
|
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place